COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,049 Articles (22,627 medRxiv, 8,422 bioRxiv)

Most recent first Previous |  Page 2850: Articles 28491-28500  | Next

The effect of a national lockdown in response to COVID-19 pandemic on the prevalence of clinical symptoms in the population
Keshet, A., Gavrieli, A., Rossman, H., Shilo, S., Meir, T., Karady, T., Lavon, A., Kolobkov, D., Kalka, I., Shoer, S., Godneva, A., Cohen, O., Zohar, A. E., Irony, A., Geiger, B., Dor, Y., Balicer, R., Shalev, V., Segal, E.
10.1101/2020.04.27.20076000 — Posted: 2020-05-01
High rate of increased level of plasma Angiotensin II and its gender difference in COVID-19: an analysis of 55 hospitalized patients with COVID-19 in a single hospital, WuHan, China
Liu, N., Hong, Y., Chen, R.-G., Zhu, H.-M.
10.1101/2020.04.27.20080432 — Posted: 2020-05-01
Clinical presentation and evolution of COVID-19 in immunosuppressed patients. Preliminary evaluation in a North Italian cohort on calcineurin-inhibitors based therapy
Cavagna, L., Bruno, R., Zanframundo, G., Gregorini, M., Seminari, E., Di Matteo, A., Rampino, T., Montecucco, C., Pelenghi, S., Cattadori, B., Pattoneri, E. F., Vitulo, P., Bertani, A., Sambataro, G., Vancheri, C., Bonetto, V., Monti, M. C., Ticozzelli, E., Turco, A., Oggionni, T., Corsico, A., Codullo, V., Morosini, M., Gnecchi, M., Pellegrini, C., Meloni, F.
10.1101/2020.04.26.20080663 — Posted: 2020-05-01
Liver Chemistries in COVID-19 Patients with Survival or Death: A Meta-Analysis
Xing, Q.-Q., Dong, X., Ren, Y.-D., Chen, W.-M., Zeng, D.-Y., Cai, Y.-Y., Hong, M.-Z., Pan, J.-S.
10.1101/2020.04.26.20080580 — Posted: 2020-05-01
Cohort profile: Preliminary experience of 500 COVID-19 postive cases at a South West London District General Hospital.
Field, R. E., Afzal, I., Dixon, J., Patel, V. R., Sarkar, P., Marsh, J. E.
10.1101/2020.04.28.20075119 — Posted: 2020-05-01
How urgent do intravitreal anti-VEGF injections need to be to justify the risk of transmitting COVID-19? Proof-of-concept calculations to determine the Health Adjusted Life-Year (HALY) trade-off.
Boyd, M. J., Scott, D. A. R., Squirrell, D. M., Wilson, G. A.
10.1101/2020.04.27.20075085 — Posted: 2020-05-01
Hydroxychloroquine application is associated with a decreased mortality in critically ill patients with COVID-19
Yu, B., Wang, D. W., Li, C.
10.1101/2020.04.27.20073379 — Posted: 2020-05-01 Discussion: Onsite
QT Interval Prolongation and Torsade De Pointes in Patients with COVID-19 treated with Hydroxychloroquine/Azithromycin
Chorin, E., Wadhwani, L., Magnani, S., Dai, M., Shulman, E., Nadeau-Routhier, C., Knots, R., Bar-Cohen, R., Kogan, E., Barbhaiya, C., Aizer, A., Holmes, D., Bernstein, S., Spinelli, M., Park, D. S., Carugo, S., Chinitz, L. A., Jankelosn, L.
10.1101/2020.04.27.20074583 — Posted: 2020-05-01
FACT- Frankfurt adjusted COVID-19 testing- a novel method enables high-throughput SARS-CoV-2 screening without loss of sensitivity
Schmidt, M., Hoehl, S., Berger, A., Zeichhardt, H., Hourfar, K., Ciesek, S., Seifried, E.
10.1101/2020.04.28.20074187 — Posted: 2020-05-01
Severe Acute Respiratory Syndrome Coronavirus 2 Serology in Asymptomatic Healthcare Professionals: Preliminary Experience of a Tertiary Italian Academic Center.
Tosato, F., Pelloso, M., Gallo, N., Giraudo, C., Llanaj, G., Cosma, C., Pozzato, C., Padoan, A., Donato, D., Plebani, M.
10.1101/2020.04.27.20073858 — Posted: 2020-05-01

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).